PMC announces next virtual breakfast briefing discussing the role of public/ private collaborations 1 Jul 2021
Virtual Breakfast Briefing: The role of public/ private collaborations to further biopharma and medical devices innovation
PMC is delighted to announce our next event on Wednesday 21st July 2021 at 8am. As the UK continues to advance its strategy of becoming a global life sciences superpower, the role of public/ private collaborations is more integral than ever before. Our next virtual briefing will incorporate a discussion of the overall landscape of public/ private collaborations and a deep dive into how MedCity is supporting innovation in the UK. Finally, we will address how pharma professionals can get involved.
Our agenda will incorporate two presentations, followed by a Q&A.
The evolution of public/ private collaborations and aspirations for the future: Dr Malcolm Barratt Johnson, Managing Director of PMC
The role of MedCity in the UK innovation ecosystem: Nicki Bromwich, Chief Operating Officer of MedCity
Key takeaways will include:
- What influence have public/ private initiatives had over the last decade? Which initiatives have had an impact?
- What opportunities do we have to promote closer collaborations in the future?
- How is MedCity enabling innovation initiatives?
- How can industry get involved in working more closely with public initiatives?
The breakfast briefings are designed to offer an easily accessible format for busy pharmaceutical professionals and will conclude before your 09.00 am meetings. We will be taking feedback during the event about the subjects you would like us to cover for the future.
Register here to attend, and feel free to forward the details to your colleagues.
PMC provides an adaptable and comprehensive medical consultancy function to start-ups, mid to late-stage pharmaceutical, biotechnology, medical device companies and academic centres. Our services span regulatory and medical affairs, product launch, licensing advice and assessment of products and product portfolios prior to investor presentations. To find out more, email firstname.lastname@example.org to arrange a discussion.
About the speakers
Dr Malcolm Barratt-Johnson
Malcolm is the Managing Director of PMC and its Senior Partner. He has over 18 years of experience as a UK / European based Consultant Pharmaceutical Physician to Industry, specialising in Medical Affairs, Product Development and Regulatory Strategy.
He lectures in both Europe and the United States on medicinal development and teaches on the King’s College London, Pharmaceutical Medicine and Regulatory MSc Course and Imperial College. In addition, Malcolm has served as a Reviewer and Chair on the European Commission’s FP7 / Horizon 2020 and Innovative Medicines Initiatives (IMI) Programmes.
Nicki is Chief Operating Officer of MedCity. She joined MedCity in 2020 following her role as Head of Commercial Development at Oxford AHSN where she managed strategic partnerships with Pharma, MedTech and digital companies, universities, and NHS organisations, and supported SMEs developing innovations.
Nicki is also a clinician with 30 years’ experience in the NHS working in a broad range of roles nationally and locally, including quality improvement, service redesign and acute care.